Science
Mechanism of Action
The precise mechanism by which S-HIV-1 Oligopeptide-6 interacts with and benefits the skin is currently unknown within the cosmetic science literature. Though broadly classified as a 'Skin Conditioning' and 'Skin Protecting' agent by some, detailed biochemical pathways or cellular targets for these effects have not been elucidated.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific data regarding the stability, optimal pH range, or solubility of S-HIV-1 Oligopeptide-6 in cosmetic formulations is not available. While the related HIV-1 protease enzyme is most active at weakly acidic conditions (pH 3.5-6.5), this does not directly indicate the stability profile of the oligopeptide itself within a cosmetic product.
Safety
Safety Profile
S-HIV-1 Oligopeptide-6 has not undergone specific safety assessments by prominent cosmetic review boards such as the Cosmetic Ingredient Review (CIR) or the SCCS. While the FDA has approved certain HIV-related compounds for pharmaceutical use, this context is distinct from cosmetic ingredient safety. Therefore, specific risk profiles, including sensitization potential, are presently undetermined.
Your Skin
Skin Compatibility
Our Assessment
Verdict
The current available data on S-HIV-1 Oligopeptide-6 in a cosmetic context is insufficient to ascertain its efficacy, safety, or optimal formulation parameters.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources